Literature DB >> 12872855

Effects of vitamin supplementation on microcirculatory disturbance in hemodialysis patients without peripheral arterial disease.

M Sato1, Y Matsumoto, H Morita, H Takemura, K Shimoi, I Amano.   

Abstract

AIMS: Dysfunctional endothelium caused by oxidative stress is thought to play a role in pathogenesis of a variety of conditions including atherosclerosis. We investigated whether a microcirculatory disturbance in hemodialysis (HD) patients was associated with increased oxidative stress and endothelial injury. PATIENTS AND METHODS: Transcutaneous oxygen tension (TcPO2) on the dorsum of the foot at rest was measured as a marker of microcirculation in 33 patients undergoing HD without clinical manifestations of peripheral arterial disease and 20 healthy controls. Furthermore, in order to examine whether TcPO2 was affected by antioxidants, oral supplementation with a combination of vitamin C (200 mg daily) and vitamin E (600 mg daily) was administered for 6 months to 8 patients with microcirculatory disturbance (TcPO2 values of 50 mmHg or less). Serum biochemical parameters including vitamins were also measured.
RESULTS: Mean TcPO2 value was significantly lower in HD patients than in control subjects (47.9 +/- 13.5 mmHg versus 62.4 +/- 11.9 mmHg, p < 0.001). After vitamin supplementation, TcPO2 values remarkably increased (40.6 +/- 10.0 mmHg versus 57.4 +/- 6.5 mmHg, p < 0.005). Serum vitamin C and vitamin E levels increased significantly as well, while serum levels of thrombomodulin, a marker of endothelial injury, and thiobarbituric acid reactants, a marker of lipid peroxidation, were significantly decreased in comparison with those before supplementation.
CONCLUSIONS: Our results suggest that the microcirculatory disturbance in HD patients seems to be associated with endothelial damage caused by oxidative stress. Combined supplementation with vitamin C and vitamin E may be of clinical benefit in improving the cutaneous microcirculation by reducing oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872855     DOI: 10.5414/cnp60028

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: a preliminary study.

Authors:  Etsuko Maeshima; Xiang-Ming Liang; Mikako Goda; Haruhisa Otani; Masatoshi Mune
Journal:  Clin Rheumatol       Date:  2006-12-02       Impact factor: 2.980

2.  A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.

Authors:  Salvatore Santo Signorelli; Pasquale Fatuzzo; Francesco Rapisarda; Sergio Neri; Margherita Ferrante; Gea Oliveri Conti; Roberto Fallico; Luigi Di Pino; Giuseppe Pennisi; Gabriella Celotta; Anzaldi Massimiliano
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Role of ascorbic acid in scavenging free radicals and lead toxicity from biosystems.

Authors:  Shabbir A Tariq
Journal:  Mol Biotechnol       Date:  2007-09       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.